Pharmacy pharmacy, the pharmacy industry’s name for the business of delivering prescription drugs to pharmacies, has long been a source of envy for many of us.
We all know someone who’s spent some time at the pharmacy counter, often without a prescription.
It’s not the most glamorous job, but it’s the most lucrative.
Somehow, the supply chain for a wide range of drugs is still largely under the thumb of drug manufacturers.
It requires far more skill and expertise than is usually the case in the pharmaceutical industry.
That is why many of the pharmacies in the United States are now looking to automate their operations.
That’s also why some pharmacists are beginning to take on a new role.
The Pharmacy, the Pharmacist is a new series in the New York magazine, highlighting the extraordinary challenges facing pharmacy managers.
In January 2018, the New England Journal of Medicine published a study that showed pharmacists were losing a million jobs in the US each year due to the pharmaceutical supply chain.
A similar study conducted by the National Bureau of Economic Research found that pharmacy managers in China lost nearly 9 million jobs last year due, in part, to the lack of competition.
According to Dr. Stephen Sondheimer, an assistant professor at the University of Pennsylvania, the US pharmacy industry is “a lot like a car.
It can be a good, safe car, but if you lose the traction, you’re going to go the wrong way.”
The pharmacy supply chain is an industry where, like cars, it’s often an easy target.
“It’s not a simple industry to predict what is going to happen in the future,” Sondheim said.
“The supply chain can be as unpredictable as the car.
So if you’re in charge of a business, you can’t be complacent about what will happen.
You have to anticipate the unknown.”
“If you’re the CEO of a company that makes cars, and you’ve got a big fleet of cars, you don’t want to lose them because your competitors are buying them and selling them for a fraction of what you’re selling them,” he added.
“It’s like a bad dream.
If you’re not on top of it, you’ll never figure out what you can do.”
The industry has long known the potential for disruption, but the pace of change is staggering.
The industry has had its share of setbacks in recent years.
A recent study found that, of the Fortune 500 companies, pharma accounted for less than 1 percent of total corporate profits.
A year earlier, the company lost over $2 billion, and another $3 billion in the following year.
Sondheimer said the pharmaceutical sector is still growing, but has not seen the kind of growth that many of his peers have.
It’s also been a difficult time for pharmacists.
“I think pharma has been a really, really tough industry,” he said.
“People are feeling a little more anxious and maybe a little bit less secure.
They’ve had some pretty bad days in the past, but they’ve also had some great ones.
I think they’re just trying to deal with it in a way that doesn’t hurt their business.”
Dr. Peter Wehner, the founder of a new company called the Pharmaceutical Research and Manufacturers of America, is in the process of building a company to support pharma in its fight against the pharmaceutical suppliers.
“In the pharmaceutical world, there’s always been this assumption that if you have a good product, they’re going out and buy more of it,” Wehner said.
But he said that the pharma industry is changing, and that is changing the way it deals with its supply chain, which has changed significantly.
“It used to be the only place where you could buy drugs from and get them to the patients, because you could order from China and get those drugs delivered,” he explained.
“Now, that’s not always possible.
It depends on how far out in the world you are.”
“There are a lot of pharmaceutical companies that have been very aggressive about expanding their reach, and now the pharmaceuticals have a very strong presence in the market,” he continued.
“There’s a lot more pressure to deliver to as many people as possible, and I think that’s the reason the supply chains have gotten so large and complicated.
It just requires more skills and more capital.
Wehner’s company, Pharmaceuticals for Progress, is hoping to bring together the knowledge and expertise of the pharmas, and provide the tools and resources for pharmacologists to take care of their own supply chains and make their own decisions.
Wehner said he believes pharma will eventually become a $1 trillion industry, with pharmaceuticals accounting for 25 percent of all new pharmaceutical sales in the U.S. The pharma sector will eventually be responsible for 60 percent of global pharmaceutical sales.